TIRC7 Inhibits T Cell Proliferation by Modulation of CTLA-4 Expression

Ab targeting of TIRC7 has been shown previously to inhibit T cell proliferation and Th1 lymphocyte-associated cytokine production. In this study, we demonstrate that Ab targeting of TIRC7 induces early cell surface expression of CTLA-4. The majority of stimulated CD4+ and CD8+ human T cells coexpress CTLA-4 and TIRC7. Similar to CTLA-4, TIRC7 rapidly accumulates at the site of Ag adhesion upon T cell activation. TIRC7 seems to colocalize with CTLA-4 in human T cells, and both molecules are associated with clathrin-coated vesicles, indicating they share intracellular transport systems. Moreover, Ab targeting of TIRC7 results in an early activation of CTLA-4 transcription. The inhibition of cell proliferation mediated by TIRC7 is dependent on CTLA-4 expression because the TIRC7-mediated inhibitory effects on cell proliferation and cytokine expression are abolished by Ab blockade of CTLA-4. Splenocytes obtained from CTLA-4-deficient mice are not responsive to TIRC7 Ab targeting. Thus, TIRC7 acts as an upstream regulatory molecule of CTLA-4 expression.

[1]  R. Lindner.  Purification of Clathrin-Coated Vesicles from Bovine Brain, Liver, and Adrenal Gland , 2006 .

[2]  B. Thiers.  Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition , 2006 .

[3]  M. Dougados,et al.  Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition. , 2005, The New England journal of medicine.

[4]  A. Sharpe,et al.  Analysis of the Role of Negative T Cell Costimulatory Pathways in CD4 and CD8 T Cell-Mediated Alloimmune Responses In Vivo1 , 2005, The Journal of Immunology.

[5]  Chul-Hyun Park,et al.  CTLA-4 Is Important in Maintaining Long-Term Survival of Cardiac Allografts , 2005, Transplantation.

[6]  H. Volk,et al.  TIRC7 Deficiency Causes In Vitro and In Vivo Augmentation of T and B Cell Activation and Cytokine Response , 2004, The Journal of Immunology.

[7]  A. Kaser,et al.  Monoclonal Antibody Specific for TIRC7 Induces Donor‐specific Anergy and Prevents Rejection of Cardiac Allografts in Mice , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  Michael Loran Dustin,et al.  The immunological synapse , 2002, Arthritis research.

[9]  D. Olive,et al.  Role of ICAM-3 in the initial interaction of T lymphocytes and APCs , 2002, Nature Immunology.

[10]  J. Egen,et al.  Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. , 2002, Immunity.

[11]  I. Taylor,et al.  Study of the interaction of the medium chain mu 2 subunit of the clathrin-associated adapter protein complex 2 with cytotoxic T-lymphocyte antigen 4 and CD28. , 2001, The Biochemical journal.

[12]  H. Schneider,et al.  A regulatory role for cytoplasmic YVKM motif in CTLA‐4 inhibition of TCR signaling , 2001, European journal of immunology.

[13]  N. Sinclair.  CTLA-4 up-regulation plays a role in tolerance mediated by CD45 , 2001, Nature Immunology.

[14]  T. Mak,et al.  Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4 , 2000, The Journal of experimental medicine.

[15]  A. Draguhn,et al.  Expression of Kv1 Potassium Channels in Mouse Hippocampal Primary Cultures: Development and Activity-Dependent Regulation , 2000, The Journal of Neuroscience.

[16]  F. Sallusto,et al.  From synapses to immunological memory: the role of sustained T cell stimulation. , 2000, Current opinion in immunology.

[17]  J. Casanova,et al.  Surface Expression of the IFN-γR2 Chain Is Regulated by Intracellular Trafficking in Human T Lymphocytes1 , 2000, The Journal of Immunology.

[18]  S. Bromley,et al.  The immunological synapse: a molecular machine controlling T cell activation. , 1999, Science.

[19]  R. Schwartz.  The new immunology--the end of immunosuppressive drug therapy? , 1999, The New England journal of medicine.

[20]  A. Sharpe,et al.  CTLA-4 and T cell activation. , 1999, Current opinion in immunology.

[21]  J. Bluestone,et al.  Molecular basis of T cell inactivation by CTLA-4. , 1998, Science.

[22]  S. Gullans,et al.  Prevention of acute allograft rejection by antibody targeting of TIRC7, a novel T cell membrane protein. , 1998, Immunity.

[23]  C. Thompson,et al.  Expression and function of CTLA-4 in Th1 and Th2 cells. , 1998, Journal of immunology.

[24]  Colin R. F. Monks,et al.  Three-dimensional segregation of supramolecular activation clusters in T cells , 1998, Nature.

[25]  C. Thompson,et al.  Brief Definitive Report Cytotoxic T Lymphocyte Antigen 4 (CTLA4) Blockade Accelerates the Acute Rejection of Cardiac Allografts in CD28-deficient Mice: CTLA4 Can Function Independently of CD28 , 2022 .

[26]  B. Wiesner,et al.  Folding and cell surface expression of the vasopressin V2 receptor: requirement of the intracellular C‐terminus , 1998, FEBS letters.

[27]  Y. Liu,et al.  Is CTLA-4 a negative regulator for T-cell activation? , 1997, Immunology today.

[28]  J. Allison,et al.  The emerging role of CTLA-4 as an immune attenuator. , 1997, Immunity.

[29]  Yuan Zhang,et al.  Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. V. Vander Heiden,et al.  Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression. , 1997, Journal of immunology.

[31]  T. Strom,et al.  Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. , 1997, Immunity.

[32]  C. Pitcher,et al.  Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. , 1997, The Journal of clinical investigation.

[33]  J. E. Celis,et al.  Cell Biology: A Laboratory Handbook , 1997 .

[34]  S. Schmid,et al.  Clathrin-coated vesicle formation and protein sorting: an integrated process. , 1997, Annual review of biochemistry.

[35]  S. Schmid,et al.  Control of EGF Receptor Signaling by Clathrin-Mediated Endocytosis , 1996, Science.

[36]  K. Bennett,et al.  Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. , 1996, Immunity.

[37]  J. Bluestone,et al.  CD28/B7 system of T cell costimulation. , 1996, Annual review of immunology.

[38]  D. Cantrell,et al.  T cell antigen receptor signal transduction pathways. , 1996, Annual review of immunology.

[39]  H. Griesser,et al.  Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4 , 1995, Science.

[40]  J. Bluestone,et al.  Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. , 1995, Immunity.

[41]  Peter S. Linsley,et al.  Cytotoxic T Lymphocyte-associated Molecule-4, a High Avidity Receptor for CD80 and CD86, Contains an Intracellular Localization Motif in Its Cytoplasmic Tail (*) , 1995, The Journal of Biological Chemistry.

[42]  P. Linsley,et al.  Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. , 1994, Immunity.

[43]  P. Linsley,et al.  CTLA-4 can function as a negative regulator of T cell activation. , 1994, Immunity.

[44]  P. Linsley,et al.  Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation , 1991, The Journal of experimental medicine.

[45]  G. Crabtree.  Contingent genetic regulatory events in T lymphocyte activation. , 1989, Science.